71 189

Cited 0 times in

전립선암의 병용 안드로젠차단요법의 임상적 반응

Other Titles
 Clinical Response of Combined Androgen Blockade in Metastatic Prostate Cancers 
Authors
 이석영  ;  김영식  ;  홍성준 
Citation
 Korean Journal of Urology (대한비뇨기과학회지), Vol.41(3) : 361-366, 2000 
Journal Title
KOREAN JOURNAL OF UROLOGY(대한비뇨기과학회지)
ISSN
 0494-4747 
Issue Date
2000
Keywords
Combined androgen blockade ; Hormone refractory prostate cancer ; Antiandrogen withdrawal syndrome
Abstract
Purpose: In Korea, there has not been a comparative study in terms of treatment methods of metastatic prostate cancer and the matter is still under investigation. We analyzed the results of CAB and tried to elucidate the clinical course of those who underwent CAB.Materials and Methods: 60 metastatic prostate cancer patients who underwent CAB from March 1991 to July 1997 and who were eligible to follow up for at least 6 months were enrolled in this study. The interval to conversion to hormonal refractory prostate cancer (HRPC) after CAB, the interval to death after conversion to HRPC and survival curve were analyzed according to initial Gleason`s score and PSA level.Results: Mean patient age was 67.2 years and mean follow-up duration was 25.4 months(6-62). During the follow-up period, 30 patients(50%) showed rise of PSA, 5(17%) of whom revealed steroid withdrawal syndrome and the remaining 25 patients were converted to HRPC. The mean interval to conversion was 18.2 months(4-43). 12 patients died and mean interval from conversion to HRPC to death was 12.2 months(5-24) and the mean survival duration after CAB of the patients who died was 28.2 months(11-53). The mean survival duration was 41.9 months(6-62). The overall(actuarial) survival rates of the whole patients were 86.2%, 65.2% and 38.4% in 2 years, 3 years and 5 years, respectively. There was no correlation between the initial PSA level and conversion to HRPC(p>0.05) but the higher the Gleason`s score was, the more likely the patient was to be converted to HRPC(p<0.05). Conclusions: In metastatic prostate cancer, initial PSA was not a predictive factor for response to CAB. But, higher initial Gleason`s score significantly correlated with higher conversion rate to HRPC. Within the limits of this study, one can at least assume that CAB is not inferior to monotherapy in its clinical results.
Files in This Item:
T200003202.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Hong, Sung Joon(홍성준) ORCID logo https://orcid.org/0000-0001-9869-065X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/172122
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links